We are live on ! Find out more
BLFS icon

BioLife Solutions

17 hedge funds and large institutions have $518K invested in BioLife Solutions in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 1717 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

15% less capital invested

Capital invested by funds: $609K → $518K (-$91K)

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BLFS Hedge Fund Activity: Q3 2016 in Review

17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2016, worth a combined $518K — down 15% from $609K a quarter earlier.

Fund positioning in BLFS was balanced in Q3 2016: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $132K. The largest seller was Credit Suisse, exiting entirely with an estimated $352K sold.

  • 17 institutional investors held BioLife Solutions (BLFS) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $518K of BioLife Solutions stock for Q3 2016, down 15% quarter-over-quarter.
  • 4 funds opened new BioLife Solutions positions in Q3 2016 and 4 closed out, a net change of 0 holders.
  • The largest BioLife Solutions buyer in Q3 2016 was Geode Capital Management, an estimated $132K added.
  • The largest BioLife Solutions seller in Q3 2016 was Credit Suisse, an estimated $352K sold.

Based on aggregated 13F filings for Q3 2016.